Validation of an Evidence-Based Educational Smartphone Application for Atopic Dermatitis

Dermatitis ◽  
2019 ◽  
Vol 30 (2) ◽  
pp. 176-177 ◽  
Author(s):  
Matthew J. Siebert ◽  
Yousuf Qureshi ◽  
Tina Chu ◽  
Heather W. Goff
2021 ◽  
Vol 12 ◽  
Author(s):  
Angelina Isabella Mellentin ◽  
W. Miles Cox ◽  
Javad S. Fadardi ◽  
Laila Martinussen ◽  
Nicolaj Mistarz ◽  
...  

Background: There is consistent evidence that community and clinical samples of individuals with an alcohol use disorder (AUD) have attentional biases toward alcohol cues. The alcohol attentional control training program (AACTP) has shown promise for retraining these biases and decreasing alcohol consumption in community samples of excessive drinkers. However, there is a lack of evidence regarding the effectiveness of ACTP in clinical AUD samples. The main aim of the present study is to investigate whether primary pharmacological and psychological, evidence-based alcohol treatment can be enhanced by the addition of a gamified AACTP smartphone application for patients with an AUD.Design and Methods: The study will be implemented as a randomized controlled trial. A total of 317 consecutively enrolled patients with AUD will be recruited from alcohol outpatient clinics in Denmark. Patients will be randomized to one of three groups upon initiation of primary alcohol treatment: Group A: a gamified AACTP smartphone application + treatment as usual (TAU); Group B: a gamified AACTP sham-control application + TAU; or Group C: only TAU. Treatment outcomes will be assessed at baseline, post-treatment, and at 3- and 6-month follow-ups. Repeated measures MANOVA will be used to compare the trajectories of the groups over time on alcohol attentional bias, alcohol craving, and drinking reductions. It is hypothesized that Group A will achieve better treatment outcomes than either Group B or Group C.Perspectives: Because attentional bias for alcohol cues is proportional to the amount of alcohol consumed, and these biases are not addressed within current evidence-based treatment programs, this study is expected to provide new evidence regarding the effectiveness of the gamified AACTP in a clinical population. Furthermore, due to promising results found using AACTP in community samples of excessive drinkers, there is a high probability that the AACTP treatment in this study will also be effective, thereby allowing AACTP to be readily implemented in clinical settings. Finally, we expect that this study will increase the effectiveness of evidence-based AUD treatment and introduce a new, low-cost gamified treatment targeting patients with an AUD. Overall, this study is likely to have an impact at the scientific, clinical, and societal levels.Clinical Trial Registration:https://clinicaltrials.gov/ct2/show/NCT05102942?term=NCT05102942&draw=2&rank=1, identifier: NCT05102942.


2020 ◽  
Vol 21 (4) ◽  
pp. 467-482
Author(s):  
Joanna Jaros ◽  
Claire Wilson ◽  
Vivian Y. Shi

2013 ◽  
Vol 17 (4) ◽  
pp. 276-282 ◽  
Author(s):  
Ashley O'Toole ◽  
Bjorn Thomas ◽  
Richard Thomas

Background: Atopic dermatitis (AD) is a chronic, relapsing, intensely pruritic dermatosis that usually affects infants, children, and young adults. The treatment of AD entails an individualized regimen that depends on the age of the patient, the stage and variety of lesions present, the sites and extent of involvement, the presence of infection, and the previous response to treatment. Objectives: To identify the evidence surrounding potential strategies for closing these gaps—ultimately improving the quality of care, the care process itself, and patient outcomes—and to encourage discussions that help develop tools to bridge the gap between suggested therapy and what is done by the patient. Methods: Review of the literature including searches on PubMed Central and Medline and in seminal dermatology texts. Results: There are several disconnections between the evidence-based guidelines in the management of AD, what the individual dermatologist recommends, and what the patient does. Conclusion: Applying the concept of the care triangle requires a balance of evidence-based medicine, the physician's experiences and the patient's needs and expectations in the decisions surrounding appropriate management of the disease.


2014 ◽  
Vol 3 (2) ◽  
Author(s):  
Jutta Ahnert ◽  
Stefan Löffler ◽  
Jochen Müller ◽  
Matthias Lukasczik ◽  
Silke Brüggemann ◽  
...  

Over the last few years, the German Pension Insurance has implemented a new method of quality assurance for inpatient rehabilitation of children and adolescents diagnosed with bronchial asthma, obesity, or atopic dermatitis: the so-called rehabilitation treatment standards (RTS). They aim at promoting a comprehensive and evidence-based care in rehabilitation. Furthermore, they are intended to make the therapeutic processes in medical rehabilitation as well as potential deficits more transparent. The development of RTS was composed of five phases during which current scientific evidence, expert knowledge, and patient expectations were included. Their core element is the specification of evidence-based treatment modules that describe a good rehabilitation standard for children diagnosed with bronchial asthma, obesity, or atopic dermatitis. Opportunities and limitations of the RTS as a tool for quality assurance are discussed.


2021 ◽  
Vol 7 (1) ◽  
pp. 7
Author(s):  
Kiran Godse ◽  
Abhiesh De ◽  
Nidhi Sharma ◽  
Murlidhar Rajagopalan ◽  
Bela Shah ◽  
...  

2020 ◽  
Author(s):  
Carmen Simone Grilo Diniz ◽  
Ana Carolina Arruda Franzon ◽  
Beatriz Fioretti-Foschi ◽  
Denise Yoshie Niy ◽  
Livia Pedrilio ◽  
...  

BACKGROUND In Brazil, and in other low-and-middle-income countries, the excess of interventions in childbirth has been associated with an increase in preterm and early term births, contributing to stagnant morbidity and mortality of mothers and babies. The fact that women often report a negative experience in vaginal childbirth, with physical pain and feelings of unsafety, neglect or abuse, may explain the high acceptability of elective cesarean sections. The recognition of the information needs and of the right to informed choice in childbirth can contribute to change this reality. The internet has been the main source of health information, but its quality is highly variable. OBJECTIVE Develop and evaluate an information/communication strategy through a smartphone application about childbirth, to facilitate informed choice for access to safer and evidence-based care, in the context of the Covid-19 pandemic. METHODS Randomized-controlled trial, with two arms (intervention and control), blind, parallel, to be conducted in a smartphone application, with women in reproductive age. After completing an entry questionnaire to verify the eligibility criteria and ethical consent, around 20,000 participants will be randomly allocated between the intervention and control groups in a 1: 1 ratio. Participants allocated to the intervention group will be invited to engage in an online information and communication strategy, designed to expand evidence-based knowledge on the advantages and disadvantages of options in labor and birth, and safety of care processes. The information is based on the guidelines of the Ministry of Health and the World Health Organization for a positive childbirth experience, and are updated to include the new challenges and disruptions in maternity care within the Covid-19 pandemic. The control group will receive information about disposable and reusable diapers as placebo intervention. The groups will be compared in their responses on a mission to prepare the birth plan, as well as in the entry and exit questionnaires, regarding answers less or more aligned with the guidelines for a positive childbirth experience. A qualitative component to map information needs is included. RESULTS The digital trial will start recruiting participants in late October 2020 and data collection is projected to finish by December 2020. CONCLUSIONS This study will evaluate an innovative intervention that has the potential to promote better communication between women and providers, so that they can make better choices and ensure their rights during the pandemic. CLINICALTRIAL Brazilian Registry of Clinical Trials – ReBEC (http://www.ensaiosclinicos.gov.br/rg/RBR-3g5f9f/). WHO’s Unique Trial Number (UTN U1111-1255-8683). This is the first version of the trial protocol.


2018 ◽  
Vol 31 (5) ◽  
pp. e12659 ◽  
Author(s):  
M. Maarouf ◽  
A. R. Vaughn ◽  
V. Y. Shi

Sign in / Sign up

Export Citation Format

Share Document